New share-owners in Panion; Clinical trial researchers and members of board and management
Panion Animal Health AB develops a novel gene therapy treatment for dogs with epilepsy. The first clinical study will be conducted at Long Island Veterinary Specialists in New York and the main veterinary clinical researchers will become share owners in Panion. Due to legal regulations, this will be handled in a procedure separate from the running share issue, which cannot be offered to persons in USA. In the same manner, a solution will now be sought for the board member, Dede Willis, and the Director of Business Development, Carlos N Velez, who both previously expressed the intention